Telomere maintenance and the etiology of adult glioma
- PMID: 26014050
- PMCID: PMC4648301
- DOI: 10.1093/neuonc/nov082
Telomere maintenance and the etiology of adult glioma
Abstract
A growing body of epidemiologic and tumor genomic research has identified an important role for telomere maintenance in glioma susceptibility, initiation, and prognosis. Telomere length has long been investigated in relation to cancer, but whether longer or shorter telomere length might be associated with glioma risk has remained elusive. Recent data address this question and are reviewed here. Common inherited variants near the telomerase-component genes TERC and TERT are associated both with longer telomere length and increased risk of glioma. Exome sequencing of glioma patients from families with multiple affected members has identified rare inherited mutations in POT1 (protection of telomeres protein 1) as high-penetrance glioma risk factors. These heritable POT1 mutations are also associated with increased telomere length in leukocytes. Tumor sequencing studies further indicate that acquired somatic mutations of TERT and ATRX are among the most frequent alterations found in adult gliomas. These mutations facilitate telomere lengthening, thus bypassing a critical mechanism of apoptosis. Although future research is needed, mounting evidence suggests that glioma is, at least in part, a disease of telomere dysregulation. Specifically, several inherited and acquired variants underlying gliomagenesis affect telomere pathways and are also associated with increased telomere length.
Keywords: genome-wide association; glioma; shelterin; telomerase; telomere.
© The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: [email protected].
Figures

Similar articles
-
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk.Oncotarget. 2015 Dec 15;6(40):42468-77. doi: 10.18632/oncotarget.6468. Oncotarget. 2015. PMID: 26646793 Free PMC article.
-
The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.J Neurooncol. 2017 Mar;132(1):1-11. doi: 10.1007/s11060-016-2349-9. Epub 2017 Jan 7. J Neurooncol. 2017. PMID: 28064387 Free PMC article. Review.
-
Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.J Neurooncol. 2020 Mar;147(1):1-14. doi: 10.1007/s11060-020-03394-y. Epub 2020 Jan 20. J Neurooncol. 2020. PMID: 31960234 Free PMC article.
-
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.Nat Genet. 2014 Jul;46(7):731-5. doi: 10.1038/ng.3004. Epub 2014 Jun 8. Nat Genet. 2014. PMID: 24908248 Free PMC article.
-
Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas.Neuro Oncol. 2024 Jun 3;26(6):1012-1024. doi: 10.1093/neuonc/noae016. Neuro Oncol. 2024. PMID: 38285162 Free PMC article. Review.
Cited by
-
Reconstructing the molecular life history of gliomas.Acta Neuropathol. 2018 May;135(5):649-670. doi: 10.1007/s00401-018-1842-y. Epub 2018 Apr 3. Acta Neuropathol. 2018. PMID: 29616301 Free PMC article.
-
Recent Molecular Advances in Our Understanding of Glioma.Cureus. 2015 Jul 23;7(7):e287. doi: 10.7759/cureus.287. eCollection 2015 Jul. Cureus. 2015. PMID: 26244119 Free PMC article. Review.
-
An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review).Mol Clin Oncol. 2023 Jun 22;19(2):61. doi: 10.3892/mco.2023.2657. eCollection 2023 Aug. Mol Clin Oncol. 2023. PMID: 37424625 Free PMC article. Review.
-
An alternative extension of telomeres related prognostic model to predict survival in lower grade glioma.J Cancer Res Clin Oncol. 2023 Nov;149(15):13575-13589. doi: 10.1007/s00432-023-05155-6. Epub 2023 Jul 29. J Cancer Res Clin Oncol. 2023. PMID: 37515613 Free PMC article.
-
Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer.Front Immunol. 2023 Jul 28;14:1218987. doi: 10.3389/fimmu.2023.1218987. eCollection 2023. Front Immunol. 2023. PMID: 37575241 Free PMC article.
References
-
- Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–466. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials